Tabula Rasa HealthCare (NYSE: MA) and Mastercard (NYSE:MA) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.
Insider and Institutional Ownership
75.2% of Tabula Rasa HealthCare shares are owned by institutional investors. Comparatively, 74.3% of Mastercard shares are owned by institutional investors. 14.0% of Tabula Rasa HealthCare shares are owned by company insiders. Comparatively, 0.3% of Mastercard shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Risk & Volatility
Tabula Rasa HealthCare has a beta of 2.71, meaning that its share price is 171% more volatile than the S&P 500. Comparatively, Mastercard has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500.
Mastercard pays an annual dividend of $1.00 per share and has a dividend yield of 0.5%. Tabula Rasa HealthCare does not pay a dividend. Mastercard pays out 21.8% of its earnings in the form of a dividend. Mastercard has increased its dividend for 6 consecutive years.
Earnings & Valuation
This table compares Tabula Rasa HealthCare and Mastercard’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Tabula Rasa HealthCare||$134.55 million||11.66||$14.29 million||($0.04)||-1,937.75|
|Mastercard||$12.50 billion||18.13||$3.92 billion||$4.58||47.64|
Mastercard has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Mastercard, indicating that it is currently the more affordable of the two stocks.
This table compares Tabula Rasa HealthCare and Mastercard’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Tabula Rasa HealthCare||-16.78%||4.55%||2.37%|
This is a summary of recent ratings and recommmendations for Tabula Rasa HealthCare and Mastercard, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Tabula Rasa HealthCare||0||2||10||0||2.83|
Tabula Rasa HealthCare currently has a consensus price target of $69.36, indicating a potential downside of 10.51%. Mastercard has a consensus price target of $208.48, indicating a potential downside of 4.45%. Given Mastercard’s stronger consensus rating and higher probable upside, analysts clearly believe Mastercard is more favorable than Tabula Rasa HealthCare.
Mastercard beats Tabula Rasa HealthCare on 14 of the 18 factors compared between the two stocks.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers related products and services. The company also offers value-added services, such as safety and security products, loyalty and reward programs, information and consulting services, issuer and acquirer processing solutions, and payment and mobile gateways. In addition, it provides various integrated products and services for account holders, merchants, financial institutions, businesses, governments, and other organizations; programs that enable issuers to provide consumers with cards to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid payment programs and management services; and commercial payment products and solutions. Further, the company provides products and services to prevent, detect, and respond to fraud and cyber-attacks, and ensure the safety of transactions. It offers payment solutions and services under the MasterCard, Maestro, and Cirrus brands. Mastercard Incorporated has a strategic partnership with Bahrain Commercial Facilities Company BSC. The company was founded in 1966 and is headquartered in Purchase, New York.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.